Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanistic Characterization of Uterine Pain (MCUP)
NCT04145518Phase 4Completed
- Sponsor
- Endeavor Health
- Start
- Oct 2019
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Aprol in dysmenorrhea (2 arms), sponsored by Endeavor Health. Primary endpoints: Number of Participants With Concordant Phenotype Assignment at Both MRI Visits, Frequency of Uterine Contractions and BOLD Oxygenation-desaturation Events by Menstrual Pain Phenotype at 1 hour and 6 more. Started Oct 2019; status: completed.
02
Drugs
Aprol
03
Conditions
dysmenorrhea
Beyond the preview
Go deeper on NCT04145518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04145518.